EP2191824
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.6.2006EP published:
14.3.2012EP application number:
09172285.0
EPO information:
European Patent Register
Title:
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
Timeline
Today
8.6.2006EP application
14.3.2012EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Kowalski, JamesAddress:
Belle Mead, NJ, US
Name:
Lakshman, Jay, ParthibanAddress:
Cedar Knolls, NJ, US
Name:
Serajuddin, Abu, T. M.Address:
Flushing, Queens, NY, US
Name:
Joshi, YatindraAddress:
Princeton, NJ, US
Priority
Number:
689719 PDate:
10.6.2005Country:
US
Number:
690309 PDate:
14.6.2005Country:
US
Classification
Categories:
A61K 31/40, A61K 9/22, A61K 9/24